HCMT
ASND icon

Highland Capital Management (Texas)’s Ascendis Pharma A/S ASND Stock Holding History

Highland Capital Management (Texas)’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-20,000
Closed -$2.35M – 321
2019
Q1 		$2.35M Buy
+20,000
New +$1.75M 0.15% 144

Other funds holding ASND

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Highland Capital Management (Texas)'s ASND Position: Q2 2019 in Review

Highland Capital Management (Texas) opened a new position in Ascendis Pharma A/S (ASND) in Q2 2019: 20,000 shares worth $2.3M. The stake represents 0.13% of the portfolio and ranks #134 among its holdings. This is a return to the name: Highland Capital Management (Texas) previously reported a position in ASND as recently as Q2 2015.

Highland Capital Management (Texas) first reported a position in ASND in Q1 2015 and has held it in 3 quarters since. 132 funds tracked by Wall St. Rank hold ASND as of Q2 2019.

  • Highland Capital Management (Texas) held 20,000 shares of Ascendis Pharma A/S worth $2.3M as of Q2 2019.
  • Ascendis Pharma A/S was a new Highland Capital Management (Texas) position in Q2 2019.
  • Ascendis Pharma A/S made up 0.13% of Highland Capital Management (Texas)'s portfolio in Q2 2019, its #134 holding.
  • Highland Capital Management (Texas) first reported a position in Ascendis Pharma A/S in Q1 2015 and has held it in 3 quarters since.
  • 132 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2019.

Based on Highland Capital Management (Texas)'s 13F filing for Q2 2019, filed 14 Aug 2019.